Understanding how a specific protein affects lung injury recovery in ARDS
Proteolysis in the Pathogenesis of ARDS
This study is looking at how a protein called MMP-3 helps heal the lungs in people with acute respiratory distress syndrome (ARDS), which can happen after things like infections or inhaling harmful substances, to find better treatments that could help patients recover faster.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | National Jewish Health NIH-funded |
| Lab location | 1 site (Denver, United States) |
| Project ID | NIH-10980513 on NIH RePORTER |
What this research studies
This research investigates the role of matrix metalloproteinase-3 (MMP-3) in the healing process of acute respiratory distress syndrome (ARDS), a severe lung condition. By using advanced cell culture techniques and animal models, the study aims to determine how MMP-3 influences the repair of lung tissue after injury caused by factors like acid aspiration or influenza infection. The findings could lead to the development of targeted therapies that selectively inhibit MMP-3 to improve recovery outcomes for patients with ARDS.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with acute respiratory distress syndrome or those at high risk of developing it.
Not a fit: Patients with chronic respiratory conditions or those not experiencing acute lung injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve recovery rates and reduce mortality in patients suffering from ARDS.
How similar studies have performed: Previous studies have shown promising results in targeting MMP-3 for lung injury treatment, indicating that this approach has potential for success.
Where this research is happening
Denver, United States
- National Jewish Health — Denver, United States (Active)
Researchers
- Principal investigator: Downey, Gregory Paul — National Jewish Health
- Study coordinator: Downey, Gregory Paul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.